Daiichi Sankyo has been listed on the Dow Jones Sustainability Indices World Index (DJSI World), the world’s leading ESG investment index in two consecutive years as the only Japanese company from the pharmaceutical sector. The Company has also been listed on the DJSI Asia Pacific in nine consecutive years.

Within DJSI World, Daiichi Sankyo received the top score among the pharmaceutical sector for Environmental Dimension. The Company was also recognized for its strong performance in the areas Occupational Health and Safety, Corporate Citizenship and Philanthropy.

Daiichi Sankyo will continue to make every effort to put into practice our corporate mission, “To contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs,” while fulfilling our social responsibility by performing CSR activities that appropriately respond to sustainability challenges as we aim to continuously enhance corporate value.